# Greenland Mines Ltd (KLTO) — capital_raise/atm_program [terminated]
Source: SEC API (secapi.ai) · situation sit_55cb693958d4ee9e0aa1 · retrieved 2026-08-11T16:12:42.350Z

## Overview
Overview Greenland Mines Ltd (the "Company" or "Greenland Mines"), formerly known as Klotho Neurosciences, Inc., develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders.

Greenland Mines Ltd. terminated its At-the-Market Sales Agreement with A.G.P./Alliance Global Partners, effective July 4, 2026. The agreement, originally dated July 3, 2025, was terminated by the Company as of right with no termination penalties incurred. No shares remain available for sale under the agreement.

## Terms
- Counterparty: A.G.P./Alliance Global Partners

## Key dates
- Expected close 2026-07-04 · Terminated 2026-07-08

## Timeline
- 2026-07-08 · 8-K (0001213900-26-076432): 8-K - Greenland Mines Ltd — Greenland Mines Ltd. terminated its At-the-Market Sales Agreement with A.G.P./Alliance Global Partners, effective July 4, 2026. The agreement, originally dated July 3, 2025, was terminated by the Company as of right with no termination penalties incurred. No shares remain available for sale under the agreement.
  https://www.sec.gov/Archives/edgar/data/1907223/0001213900-26-076432.txt

## Citations
- 0001213900-26-076432 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026076432